Linked Life Data

19560232

Source:http://linkedlifedata.com/resource/pubmed/id/19560232

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19560232rdf:typepubmed:Citationlld:pubmed
pubmed-article:19560232lifeskim:mentionsumls-concept:C0752347lld:lifeskim
pubmed-article:19560232lifeskim:mentionsumls-concept:C1306673lld:lifeskim
pubmed-article:19560232lifeskim:mentionsumls-concept:C0868928lld:lifeskim
pubmed-article:19560232lifeskim:mentionsumls-concept:C1882932lld:lifeskim
pubmed-article:19560232lifeskim:mentionsumls-concept:C1709630lld:lifeskim
pubmed-article:19560232pubmed:issue5lld:pubmed
pubmed-article:19560232pubmed:dateCreated2011-4-18lld:pubmed
pubmed-article:19560232pubmed:abstractTextLewy pathology occurs in 8-17% of neurologically normal people age >60, termed incidental Lewy body disease (iLBD). It is often assumed to represent preclinical Parkinson disease (PD). However, some iLBD cases have diffuse pathology inconsistent with preclinical PD. We analyzed iLBD cases (?-synuclein immunohistochemistry) using the Braak PD staging scheme and determined if some had a neuropathological pattern suggestive of preclinical dementia with Lewy bodies (DLB). Of the 235 brains examined, 34 had iLBD (14.5%) and all but one could be assigned a Braak PD stage. The distribution of ?-synuclein pathology in the 33 cases fell into three patterns: (1) diffuse cortical and subcortical ?-synuclein pathology; (2) no cortical ?-synuclein pathology, but a caudal-to-rostral ascending pattern, primarily involving brainstem; and (3) intermediate between these two categories. Also, 6/33 cases failed to follow the pattern of contiguous spread proposed by Braak. These findings suggest dichotomy in the distribution of iLBD: some cases fit the Braak ascending scheme, conceptually consistent with preclinical PD, whereas others displayed prominent cortical involvement that might represent preclinical DLB.lld:pubmed
pubmed-article:19560232pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19560232pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19560232pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19560232pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19560232pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19560232pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19560232pubmed:languageenglld:pubmed
pubmed-article:19560232pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19560232pubmed:citationSubsetIMlld:pubmed
pubmed-article:19560232pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19560232pubmed:statusMEDLINElld:pubmed
pubmed-article:19560232pubmed:monthMaylld:pubmed
pubmed-article:19560232pubmed:issn1558-1497lld:pubmed
pubmed-article:19560232pubmed:authorpubmed-author:DicksonDennis...lld:pubmed
pubmed-article:19560232pubmed:authorpubmed-author:MaraganoreDem...lld:pubmed
pubmed-article:19560232pubmed:authorpubmed-author:AhlskogJ...lld:pubmed
pubmed-article:19560232pubmed:authorpubmed-author:ParisiJoseph...lld:pubmed
pubmed-article:19560232pubmed:authorpubmed-author:BoeveBradley...lld:pubmed
pubmed-article:19560232pubmed:authorpubmed-author:DelleDonneAnt...lld:pubmed
pubmed-article:19560232pubmed:authorpubmed-author:JosephsKeith...lld:pubmed
pubmed-article:19560232pubmed:authorpubmed-author:AhnTae-BeomTBlld:pubmed
pubmed-article:19560232pubmed:authorpubmed-author:KlosKevin JKJlld:pubmed
pubmed-article:19560232pubmed:authorpubmed-author:FrigerioRober...lld:pubmed
pubmed-article:19560232pubmed:authorpubmed-author:FujishiroHiro...lld:pubmed
pubmed-article:19560232pubmed:copyrightInfoCopyright © 2009 Elsevier Inc. All rights reserved.lld:pubmed
pubmed-article:19560232pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19560232pubmed:volume32lld:pubmed
pubmed-article:19560232pubmed:ownerNLMlld:pubmed
pubmed-article:19560232pubmed:authorsCompleteYlld:pubmed
pubmed-article:19560232pubmed:pagination857-63lld:pubmed
pubmed-article:19560232pubmed:dateRevised2011-9-22lld:pubmed
pubmed-article:19560232pubmed:meshHeadingpubmed-meshheading:19560232...lld:pubmed
pubmed-article:19560232pubmed:meshHeadingpubmed-meshheading:19560232...lld:pubmed
pubmed-article:19560232pubmed:meshHeadingpubmed-meshheading:19560232...lld:pubmed
pubmed-article:19560232pubmed:meshHeadingpubmed-meshheading:19560232...lld:pubmed
pubmed-article:19560232pubmed:meshHeadingpubmed-meshheading:19560232...lld:pubmed
pubmed-article:19560232pubmed:meshHeadingpubmed-meshheading:19560232...lld:pubmed
pubmed-article:19560232pubmed:meshHeadingpubmed-meshheading:19560232...lld:pubmed
pubmed-article:19560232pubmed:meshHeadingpubmed-meshheading:19560232...lld:pubmed
pubmed-article:19560232pubmed:meshHeadingpubmed-meshheading:19560232...lld:pubmed
pubmed-article:19560232pubmed:meshHeadingpubmed-meshheading:19560232...lld:pubmed
pubmed-article:19560232pubmed:meshHeadingpubmed-meshheading:19560232...lld:pubmed
pubmed-article:19560232pubmed:meshHeadingpubmed-meshheading:19560232...lld:pubmed
pubmed-article:19560232pubmed:meshHeadingpubmed-meshheading:19560232...lld:pubmed
pubmed-article:19560232pubmed:year2011lld:pubmed
pubmed-article:19560232pubmed:articleTitleIncidental Lewy body disease: do some cases represent a preclinical stage of dementia with Lewy bodies?lld:pubmed
pubmed-article:19560232pubmed:affiliationDepartment of Neurology, Mayo Clinic, Rochester, MN, United States.lld:pubmed
pubmed-article:19560232pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19560232pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed